Mitochondrial DNA mutations in pancreatic cancer

International Journal of Gastrointestinal Cancer

Volumn 37, Issue 2-3, 2006, Pages 57-64

  Kassauei, Keyanoosh ^a   Habbe, Nils ^a   Mullendore, Michael E ^a   Karikari, Collins A ^a   Maitra, Anirban ^a   Feldmann, Georg ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Field defect; MitoChip; Mitochondrial mutations; Pancreatic cancer

Indexed keywords

BIOLOGICAL MARKER; MITOCHONDRIAL DNA; RIBOSOME RNA; RNA 12S; RNA 16S; TRANSFER RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; AUTOMATION; CANCER DIAGNOSIS; CELL IMMORTALIZATION; CHEMICAL LABELING; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA EXTRACTION; DNA ISOLATION; DNA MICROARRAY; DNA SEQUENCE; FROZEN SECTION; GENE MUTATION; GENOME ANALYSIS; GENOTYPE; GERM LINE; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE; MICROARRAY ANALYSIS; MITOCHONDRIAL GENETICS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS RESECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOMATIC MUTATION;

DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; DNA, NEOPLASM; GENOME, MITOCHONDRIAL; GENOTYPE; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREAS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 35348857507     PISSN: 15373649     EISSN: 15590739     Source Type: Journal    
DOI: 10.1007/s12029-007-0008-2     Document Type: Article

References (30)

1. Maitra A, Kern SE, Hruban RH. Molecular pathogenesis of pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:211-26.
2. Rosty C, Goggins M. Early detection of pancreatic carcinoma. Hematol Oncol Clin North Am 2002;16:37-52.
3. Kagan J, Srivastava S. Mitochondria as a target for early detection and diagnosis of cancer. Crit Rev Clin Lab Sci 2005;42:453-72.
4. Chatterjee A, Mambo E, Sidransky D. Mitochondrial DNA mutations in human cancer. Oncogene 2006;25:4663-74.
5. Mambo E, Gao X, Cohen Y, Guo Z, Talalay P, Sidransky D. Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc Natl Acad Sci USA 2003;100:1838-43.
6. Jones JB, Song JJ, Hempen PM, Parmigiani G, Hruban RH, Kern SE. Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. Cancer Res 2001;61:1299-304.
7. Sui G, Zhou S, Wang J, Canto M, Lee EE, Eshleman JR, et al. Mitochondrial DNA mutations in preneoplastic lesions of the gastrointestinal tract: a biomarker for the early detection of cancer. Mol Cancer 2006;5:73.
8. Jakupciak JP, Dakubo GD, Maragh S, Parr RL. Analysis of potential cancer biomarkers in mitochondrial DNA. Curr Opin Mol Ther 2006;8:500-6.
9. Jakupciak JP, Wang W, Markowitz ME, Ally D, Coble M, Srivastava S, et al. Mitochondrial DNA as a cancer biomarker. J Mol Diagnostics 2005;7:258-67.
10. Maitra A, Cohen Y, Gillespie SE, Mambo E, Fukushima N, Hoque MO, et al. The human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res 2004;14:812-9.
11. Zhou S, Kassauei K, Cutler DJ, Kennedy GC, Sidransky D, Maitra A, et al. An oligonucleotide microarray for high-throughput sequencing of the mitochondrial genome. J Mol Diagnostics 2006;8:476-82.
12. Jacobs L, Gerards M, Chinnery P, Dumoulin J, de Coo I, Geraedts J, et al. mtDNA point mutations are present at various levels of heteroplasmy in human oocytes. Mol Hum Reprod 2007;13:9-14.
13. van Eijsden RG, Gerards M, Eijssen LM, Hendrickx AT, Jongbloed RJ, Wokke JH, et al. Chip-based mtDNA mutation screening enables fast and reliable genetic diagnosis of OXPHOS patients. Genet Med 2006;8:620-7.
14. Coon KD, Valla J, Szelinger S, Schneider LE, Niedzielko TL, Brown KM, et al. Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. Mitochondrion 2006;6:194-210.
15. Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K, et al. Genomic alterations in cultured human embryonic stem cells. Nat Genet 2005;37:1099-103.
16. Josephson R, Sykes G, Liu Y, Ording C, Xu W, Zeng X, et al. A molecular scheme for improved characterization of human embryonic stem cell lines. BMC Biol 2006;4:28.
17. Cutler DJ, Zwick ME, Carrasquillo MM, Yohn CT, Tobin KP, Kashuk C, et al. High-throughput variation detection and genotyping using microarrays. Genome Res 2001;11:1913-25.
18. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 1999;23:147.
19. Giovannucci E, Ogino S. DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst 2005;97:1317-9.
20. Guo M, House MG, Hooker C, Han Y, Heath E, Gabrielson E, et al. Promoter hypermethylation of resected bronchial margins: a field defect of changes? Clin Cancer Res 2004;10:5131-6.
21. Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Cancer Res 1996;56:3409-14.
22. Calhoun ES, Jones JB, Ashfaq R, Adsay V, Baker SJ, Valentine V, et al. BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. Am J Pathol 2003;163:1255-60.
23. Lohr M, Maisonneuve P, Lowenfels AB. K-Ras mutations and benign pancreatic disease. Int J Pancreatol 2000;27:93-103.
24. Ha PK, Tong BC, Westra WH, Sanchez-Cespedes M, Parrella P, Zahurak M, et al. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin Cancer Res 2002;8:2260-5.
25. Jeronimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, Varzim G, et al. Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 2001;20:5195-8.
26. Tang M, Baez S, Pruyas M, Diaz A, Calvo A, Riquelme E, et al. Mitochondrial DNA mutation at the D310 (displacement loop) mononucleotide sequence in the pathogenesis of gallbladder carcinoma. Clin Cancer Res 2004;10:1041-6.
27. Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P, Thilly WG. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet 2001;28:147-50.
28. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005;102:719-24.
29. Bashir R, Masih A, Kallweit K, Fordyce-Boyer R, Sanger W, Purtilo D. Evolution of clonality and invasive behavior of Epstein-Barr virus immortalized lymphoblastoid cell lines in SCID mice brains. Lab Invest 1992;67:450-6.
30. Ryan JL, Kaufmann WK, Raab-Traub N, Oglesbee SE, Carey LA, Gulley ML. Clonal evolution of lymphoblastoid cell lines. Lab Invest 2006;86:1193-200.